York Space Systems (NYSE: YSS) Securities Class Action: IPO, Tranche 3 Funding, Revenue Guidance and October 30, 2026 Lead Plaintiff Deadline

The lawsuits allege that York went public while failing to adequately disclose significant problems involving the company's most important government program. Plaintiff alleges that before the IPO, York had experienced delays and technical problems under its Space Development Agency contracts, the Pentagon had already moved away from funding the planned Tranche 3 Transport Layer, and York's future contract opportunities were therefore materially impaired — yet York's offering materials nevertheless emphasized its technological performance, delivery history, and incumbent position in future PWSA programs.

Two features make this more than a generic 'a government customer cut spending' case: it is built on York's January 2026 IPO disclosures (not just later statements), and it runs on two distinct legal tracks explained below. The allegations have not been proven.

This case is unusual because it pleads two different groups of claims, and a single investor may fall into both.

Track 1 — Securities Act claims (the IPO)

For investors who bought YSS common shares in or traceable to the January 2026 IPO, the complaint asserts Section 11 (materially misleading registration statement) and Section 15 (control-person liability). Critically, the complaint states its Section 11 count 'does not sound in fraud' — a §11 plaintiff does not need to plead or prove scienter or fraudulent intent, and York as issuer can face strict §11 liability for a qualifying registration-statement defect. This is the key difference from a fraud claim.

Track 2 — Exchange Act claims (open-market buyers)

For investors who bought YSS in the open market between January 29 and August 13, 2026, the complaint asserts Section 10(b) and Rule 10b-5 (a fraud claim requiring material falsity, scienter, reliance, loss causation, and damages) plus Section 20(a) control-person claims. The individual officers, York's sponsor AE Industrial Partners, and the IPO underwriters (including Goldman Sachs, Jefferies, Wells Fargo Securities, J.P. Morgan, and Citigroup, among others) are named across these theories.

A Section 11 claim is not automatic for everyone who ever owned YSS. The Supreme Court held in Slack Technologies v. Pirani that a §11 plaintiff must plead and prove that the specific shares purchased were registered under the challenged registration statement. Investors who bought directly in York's IPO have the clearest traceability path; investors who bought later in the public market may face a separate, fact-specific question about whether their particular shares can be traced to the IPO registration statement — a question made harder because York later issued additional shares in connection with acquisitions. This page does not make a categorical eligibility determination; that depends on each investor's own purchase history.

Yes — multiple overlapping York Space Systems securities complaints are pending in the District of Colorado. Ianelli was filed first (August 31, 2026) and generally covered IPO/traceable purchasers and buyers from January 29 to May 11, 2026. The later Teamsters Local 710 Pension Fund complaint (October 19, 2026) extends the Exchange Act class period through August 13, 2026 and adds substantial additional allegations.

Importantly, the later complaint did not reset the deadline. The currently published PSLRA lead-plaintiff deadline remains October 30, 2026 — it is not recalculated from the October 19 filing. Future court proceedings may address coordination or consolidation of the overlapping actions.

York builds satellites, spacecraft platforms, satellite software, mission systems, ground systems, and related defense-space technology for national-security, government, and commercial customers. Historically its principal business has been national-security space, and it has been highly dependent on one U.S. government customer — the Space Development Agency (SDA). York's own 2025 Form 10-K states that approximately 96% of 2025 revenue came from one customer and that SDA accounted for substantially all of the company's revenue and backlog — an extraordinary customer concentration that is important context throughout this case.

The Space Development Agency is part of the U.S. Space Force. Among its major programs is the Proliferated Warfighter Space Architecture (PWSA) — a distributed low-Earth-orbit military satellite architecture. Two of its components matter here: the Tracking Layer (which detects and tracks threats such as ballistic missiles and hypersonic weapons) and the Transport Layer (the communications network that moves data among satellites, sensors, command systems, and weapons platforms).

PWSA was developed in successive generations called 'tranches.' York won substantial Transport Layer work in Tranche 0, Tranche 1, and Tranche 2, and its IPO materials described that record as creating an incumbent advantage heading into Tranches 3 and 4.

York's registration statement described the company as having 'world-class technical expertise,' 'proven execution,' differentiated performance on price, deployment speed and capability, and a leading PWSA position — stating it was the number-one PWSA provider by several metrics and emphasizing its incumbent position for future tranches. The complaint alleges those statements were misleading because of preexisting technical defects, software deficiencies, schedule delays, and a failure to timely establish minimum viable capabilities — and because the Tranche 3 funding picture had already turned against York before the offering.

Public reporting in June 2025 showed that the Space Force's FY2026 budget request contained no funding for the planned Tranche 3 Transport Layer, while the service considered a different communications architecture. Congress considered restoring more, but the final FY2026 defense appropriations provided only about $50 million to maintain 'warfighter-centric capabilities' within PWSA. By April 2026 a Space Force official stated publicly that 'the Transport Layer for Tranche 3 is not funded,' and relevant requirements were migrating into a new Space Data Network (SDN) architecture.

The timing is central to the IPO theory: York priced its IPO on January 28 and began trading January 29, while the FY2026 appropriations were signed February 3. The complaint alleges the underlying Pentagon policy decision existed before the IPO even though the final enacted appropriation came days later — and that York's risk factors wrongly described the funding risk as a future possibility when the adverse decision had allegedly already substantially materialized (invoking Regulation S-K Item 303 on known trends and Item 105 on material risk factors).

That is an allegation — not an established Pentagon finding, and the distinction matters. Public government records confirm that the government moved away from funding the planned Tranche 3 Transport Layer, shifted architecture, and moved toward the Space Data Network. The complaint further alleges that York's own performance problems materially contributed to that decision — but that specific causation theory is pleaded by plaintiff and rests largely on a short-seller report (Wolfpack Research), anonymous and former-employee accounts, and plaintiff's inference. The government sources reviewed for this page do not themselves state that York's performance was the reason for the funding decision.

The complaint treats the enacted FY2026 appropriations measure — which provided no dedicated material Tranche 3 Transport Layer appropriation and only about $50 million for continued PWSA warfighter-centric capability — as an early partial revelation. According to the complaint, YSS declined from $26.52 on February 3 to $23.13 on February 5, about 13%.

York reported FY2025 revenue of about $386.2 million (up roughly 52%), with gross profit up about 133% and a net loss of about $84.5 million. It then issued full-year 2026 revenue guidance of $545–$595 million (midpoint $570 million), stating that more than 70% of midpoint revenue was expected to come from existing backlog. The complaint alleges that forecast lacked a reasonable basis because its new-government-business assumptions were already impaired.

Asked whether the PWSA architecture was materially changing, CEO Dirk Wallinger emphasized that the military's communications requirement remained and said, in substance, 'There's nothing going away.' Plaintiff alleges that statement minimized the significance of the government's shift away from Tranche 3; in fairness, Wallinger's broader point was that demand for resilient military communications continued even if the program name or acquisition structure changed — and later government actions did confirm continued space-communications spending, just not through the expected Tranche 3 structure.

On May 11, 2026, the short seller Wolfpack Research published a report titled 'YSS: Lost In Space — The Pentagon Just Killed 96% of York's Revenue,' and expressly disclosed that it was short YSS — meaning it stood to profit if the stock fell, a material economic interest to weigh when reading its claims. Relying on people it identified as former employees, Wolfpack alleged incomplete flight software, in-orbit debugging, schedule pressure, testing shortcuts, and that York's performance may have contributed to the Pentagon's Tranche 3 decision.

Two cautions. Wolfpack's causation claim was framed as a suspicion or inference — not a Pentagon finding that York was defective — so these remain allegations, attributed to Wolfpack and former employees, that have not been adjudicated. And the '96%' headline refers to York's historical one-customer revenue concentration (per its 10-K); the government did not cancel already-earned historical revenue, so it would be inaccurate to say 'the Pentagon killed 96% of York's revenue' — the issue concerns future business and future procurement.

Three days after the Wolfpack report, York reported Q1 2026 revenue of about $116.3 million (up roughly 9%) but a substantially larger net loss (about $114.8 million), and expressly reaffirmed its $545–$595 million full-year guidance. Management acknowledged near-term supply-chain delays but said 'unprecedented bid activity in other areas' could offset them. The complaint emphasizes that reaffirmation as part of its continuing-fraud theory. According to the complaint, YSS fell from $28.94 on May 14 to $24.02 on May 15, about 17%.

On May 26, the U.S. Space Force awarded SpaceX an approximately $2.29 billion firm-fixed-price agreement to build the Space Data Network Backbone — significant because it showed the new architecture was not merely a renamed York/SDA Tranche 3 procurement. But the official announcement also said the broader network would remain integrated, the government intended additional industry participation, and competition would continue in other elements. So this is not a case of the military no longer needing space communications (it plainly does, and SDN remains a major program) — the issue is whether York accurately described its probability and timing of capturing that spending. It would overstate the record to say SpaceX received every future opportunity York could have won.

York announced on August 5 that CFO Kevin Messerle would step down effective August 14, with Brian Frantz becoming interim CFO. The complaint cites the timing — just before the Q2 report and guidance cut — as part of its scienter theory and alleges the departure was unplanned.

That allegation must be read with York's express statement: the company said Messerle was pursuing an opportunity outside the space industry and that his departure was not the result of any disagreement concerning York's operations, policies, or practices. It should not be characterized as an accounting-related resignation. According to the complaint, YSS fell from $13.15 to $10.89 after the announcement, about 17%.

York reported Q2 2026 revenue of about $92.5 million (up roughly 10%, with gross profit up about 133%) and substantially cut its 2026 revenue guidance — from $545–$595 million (midpoint $570 million) to $375–$405 million (midpoint $390 million), a midpoint reduction of about $180 million that the complaint notes exceeded the roughly $171 million of new-business revenue previously embedded in the forecast. York did not say 'Tranche 3 killed our business'; it attributed the majority of the cut to removing expected new-business revenue from 2026 because of shifts in government acquisition methodologies, and also cited supply-chain timing, revenue shifting into 2027, acquisitions, and longer IDIQ procurement cycles.

For balance, York's Q2 was not a collapse: alongside the cut it reported about $534 million of cash and roughly $684 million of total liquidity, eight year-to-date contract wins and an 88% win rate, about $592 million of backlog, roughly $1.85 billion of potential value on awarded contracts, and an identified pipeline of about $11.5 billion. The litigation concerns whether York's earlier disclosures and revenue expectations were misleading — not whether York had no remaining business. According to the complaint, YSS slipped about 5% on August 14 and later traded well below its $34 IPO price (the complaint alleges below $6 by the time of filing — more than 80% below the IPO price).

AE Industrial Partners was York's private-equity sponsor. Following the IPO, AE Industrial funds held roughly 24% of York's outstanding shares but, through voting arrangements, controlled more than 50% of the voting power for electing directors — so York qualified as a 'controlled company' under NYSE rules, which lets it rely on exemptions from certain governance requirements.

Importantly, that control and controlled-company status were expressly disclosed in the IPO materials — it was not concealed, and it is a governance structure, not itself wrongdoing. The complaint asserts §15 and §20(a) control-person claims against AE Industrial. Separately, SEC Forms 4 show AE Industrial-affiliated funds received York shares as former investors in acquisition targets (Solestial and ALL.SPACE) — those were acquisition-consideration transactions, not open-market insider sales, and should not be described as 'AE Industrial insider selling.'

Yes. During 2026 York acquired Orbion Space Technology (March), Solestial (closed June 4), and ALL.SPACE (agreed April 29, closed July 8, at roughly $355 million with about $155 million cash and up to 5.9 million YSS shares), using substantial YSS stock as consideration. The complaint cites the use of York stock as acquisition currency as part of its scienter/motive theory — alleging an incentive to keep the share price inflated — but that does not establish that the acquisitions themselves were improper. York described the transactions as strategic efforts to vertically integrate, strengthen supply chains, expand communications capabilities, and diversify. Both perspectives belong on the record.

The current complaints do not principally rely on an officer insider-selling theory. York disclosed IPO lock-up restrictions affecting officers, directors, AE Industrial, and other pre-IPO shareholders that limited near-term public selling, and the stronger scienter allegations here concern the IPO itself, government-contract risk, revenue guidance, the use of stock as acquisition currency, AE Industrial's control, and the CFO transition. Julie & Holleman therefore does not presently characterize this as an insider-trading case.

For the Exchange Act claims, the newer complaint alleges a class period of January 29, 2026 through August 13, 2026. Separately, IPO investors may have Securities Act (§11) claims if their YSS common shares were purchased in or traceable to the January 2026 IPO. One investor may fall into both groups, and investors should preserve brokerage records showing whether their shares were bought in the IPO or in the open market, and when.

The current published PSLRA lead plaintiff deadline is October 30, 2026. The October 19 extended complaint did not reset it.

Do I Have to Become Lead Plaintiff?

Generally, no. A lead plaintiff is the investor or investor group the court appoints to actively supervise the proposed class and proposed lead counsel. Most investors remain passive class members.

Lead Plaintiff Deadline ≠ Settlement Claim Deadline

These are different dates. An eligible investor ordinarily does not need to seek lead-plaintiff appointment merely to remain a potential passive class member.

Generally, no, for the federal investor securities claims — continued ownership is not required, and standing, loss causation, and damages turn on matters including purchase and sale timing. Current ownership presents different issues for potential shareholder derivative or corporate-governance claims, discussed below.

Potentially. York Space Systems is a Delaware corporation, so any shareholder derivative or internal-affairs analysis generally begins with Delaware law. Julie & Holleman LLP is investigating whether current shareholders may have separate corporate-governance rights relating to offering disclosure, core-customer and government-contract oversight, technical-performance oversight, revenue guidance, AE Industrial's control, the acquisitions, and board oversight.

One wrinkle is specific to York: it converted from a privately held Delaware LLC (Yellowstone Midco Holdings II, LLC) into a Delaware corporation immediately before the IPO, which may create additional standing and internal-affairs questions for claims concerning pre-IPO conduct — so any potential claim should be evaluated against the specific challenged act and the shareholder's own ownership history. Counsel may evaluate whether a Delaware books-and-records investigation or other steps are appropriate for a qualifying current York shareholder; because York is a national-security contractor, such an investigation would not provide access to classified technical specifications, military communications designs, or classified contract-performance records. No determination has been made that viable derivative claims exist, and no overlapping derivative action based on these specific allegations was identified in the public sources reviewed.

Julie & Holleman LLP is investigating allegations involving York Space Systems Inc., YSS, Dirk Wallinger, Kevin Messerle, Brian Frantz, AE Industrial Partners, the IPO underwriters (including Goldman Sachs, Jefferies, Wells Fargo Securities, J.P. Morgan, and Citigroup), York's January 2026 IPO, the Space Development Agency, PWSA, the Transport Layer, Tranche 3, the Space Data Network, Wolfpack Research, satellite software, government-contract performance, revenue guidance, and corporate governance. We are interested in hearing from:

IPO Investors

Investors who purchased YSS common stock in or traceable to York's January 2026 IPO.

Open-Market (Exchange Act) Investors

Investors who purchased YSS common stock between January 29, 2026 and August 13, 2026 and suffered losses. One investor may fall into both groups. Investors considering lead-plaintiff appointment should note the current deadline of October 30, 2026.